Indocin: Targeted Relief for Inflammation and Pain
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.50 | $45.20 (0%) | 🛒 Add to cart |
| 180 | $0.40 | $90.41 $72.33 (20%) | 🛒 Add to cart |
| 270 | $0.37 | $135.61 $99.45 (27%) | 🛒 Add to cart |
| 360 | $0.35
Best per pill | $180.82 $125.57 (31%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.22 (0%) | 🛒 Add to cart |
| 90 | $0.69 | $73.83 $62.28 (16%) | 🛒 Add to cart |
| 120 | $0.62 | $98.44 $74.34 (24%) | 🛒 Add to cart |
| 180 | $0.55 | $147.67 $98.44 (33%) | 🛒 Add to cart |
| 270 | $0.51 | $221.50 $137.62 (38%) | 🛒 Add to cart |
| 360 | $0.49
Best per pill | $295.33 $175.79 (40%) | 🛒 Add to cart |
Indocin (indomethacin) is a potent nonsteroidal anti-inflammatory drug (NSAID) prescribed for the management of moderate to severe inflammatory conditions. It works by inhibiting prostaglandin synthesis, substances in the body that cause inflammation, pain, and fever. This medication is particularly effective in treating rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute gouty arthritis. Available in various formulations including capsules, suppositories, and oral suspension, Indocin offers flexibility in administration tailored to individual patient needs and severity of symptoms. Its use is strictly under medical supervision to maximize therapeutic benefits while minimizing potential risks.
Features
- Active ingredient: Indomethacin
- Available forms: 25 mg and 50 mg capsules, 75 mg extended-release capsules, 25 mg/5 mL oral suspension, 50 mg rectal suppositories
- Mechanism: Nonsteroidal anti-inflammatory drug (NSAID), cyclooxygenase (COX) inhibitor
- Prescription status: Rx-only
- Half-life: Approximately 4.5 hours (immediate-release); 5-6 hours (extended-release)
- Onset of action: 1-2 hours (oral); 30-60 minutes (rectal)
- Metabolism: Hepatic, primarily via CYP2C9
- Excretion: Renal (60%) and fecal (33%)
Benefits
- Provides significant reduction in inflammation, swelling, and joint stiffness associated with arthritic conditions
- Offers rapid relief from acute pain, particularly in gout attacks and postoperative settings
- Improves mobility and functional capacity in chronic inflammatory disorders
- Reduces fever in refractory cases where other antipyretics are ineffective
- Available in multiple formulations allowing for tailored dosing strategies
- Demonstrated efficacy in closing patent ductus arteriosus in premature infants (IV formulation)
Common use
Indocin is primarily prescribed for the treatment of inflammatory and painful conditions. Its most common applications include rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis, where it helps reduce joint inflammation and pain. It is particularly effective in managing acute gouty arthritis, providing relief from severe pain and inflammation within hours of administration. Additionally, Indocin is used for postoperative pain management, especially following orthopedic procedures. The intravenous formulation is specifically employed in neonatal intensive care units to medically close patent ductus arteriosus in premature infants. Off-label uses may include treatment of pericarditis and certain headache syndromes, though these applications require careful medical supervision.
Dosage and direction
Dosage must be individualized based on the condition being treated, formulation used, and patient response. For rheumatoid arthritis and osteoarthritis, the typical starting dose is 25 mg two or three times daily, which may be increased to 150-200 mg daily in divided doses. For acute gouty arthritis, the recommended dose is 50 mg three times daily until pain is tolerable, then rapidly tapered. Extended-release capsules (75 mg) are typically administered once or twice daily. Rectal suppositories (50 mg) may be used once or twice daily when oral administration is not feasible. For patent ductus arteriosus in infants, dosing is weight-based and administered intravenously under strict medical supervision. Always take with food or milk to minimize gastrointestinal upset. Do not crush or chew extended-release formulations.
Precautions
Patients should be monitored regularly for gastrointestinal bleeding, particularly those with history of peptic ulcer disease. Renal function should be assessed before initiation and periodically during therapy, especially in elderly patients or those with pre-existing renal impairment. Cardiovascular risk assessment is crucial, as NSAIDs may increase the risk of thrombotic events. Use with caution in patients with hypertension, as Indocin may elevate blood pressure. Hepatic function monitoring is recommended during prolonged therapy. Patients should avoid alcohol consumption during treatment due to increased risk of gastrointestinal bleeding. Caution is advised when operating machinery or driving, as dizziness and drowsiness may occur.
Contraindications
Indocin is contraindicated in patients with known hypersensitivity to indomethacin, aspirin, or other NSAIDs. It should not be used in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Contraindications include history of gastrointestinal bleeding or perforation related to previous NSAID therapy. Active peptic ulcer disease or recent gastrointestinal bleeding represents absolute contraindications. Severe hepatic impairment or active liver disease prohibits use. The drug is contraindicated in the third trimester of pregnancy due to risk of premature closure of ductus arteriosus. It should not be used in patients with severe heart failure or following coronary artery bypass graft (CABG) surgery.
Possible side effect
Common side effects include gastrointestinal symptoms such as nausea (10-15%), dyspepsia (10-12%), abdominal pain (5-8%), and diarrhea (3-5%). Central nervous system effects may include headache (10-15%), dizziness (5-8%), and drowsiness (3-5%). Serious adverse reactions include gastrointestinal bleeding (1-2%), peptic ulceration (2-3%), and renal impairment (1-2%). Cardiovascular risks include increased blood pressure (5-8%) and elevated risk of thrombotic events. Hepatic enzyme elevations may occur in 5-10% of patients. Rare but serious side effects include Stevens-Johnson syndrome, toxic epidermal necrolysis, and anaphylactic reactions. Patients should immediately report any signs of bleeding, chest pain, shortness of breath, weakness on one side, or slurred speech.
Drug interaction
Indocin interacts significantly with several medication classes. It may increase lithium levels by reducing renal clearance, requiring close monitoring. Concurrent use with other NSAIDs or aspirin increases gastrointestinal bleeding risk. Anticoagulants like warfarin have enhanced effects when combined with Indocin, increasing bleeding risk. ACE inhibitors and angiotensin receptor blockers may have reduced antihypertensive effects. Diuretics may have reduced efficacy when used concomitantly. Indocin may increase methotrexate toxicity by reducing renal clearance. Cyclosporine levels may increase, enhancing nephrotoxicity. SSRIs and SNRIs may further increase bleeding risk. Corticosteroids potentiate the risk of gastrointestinal ulceration. Always inform your physician of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. For extended-release formulations, if remembered within 8 hours of the scheduled time, take the missed dose. If more than 8 hours have passed, skip the dose and resume normal schedule. Maintaining consistent blood levels is important for therapeutic effect, but occasional missed doses are generally not critical for chronic conditions. However, for acute conditions like gout, consistent dosing is more crucial during the initial treatment phase.
Overdose
Indomethacin overdose may manifest as severe nausea, vomiting, intense abdominal pain, headache, drowsiness, or lethargy. More serious effects include gastrointestinal bleeding, acute renal failure, respiratory depression, seizures, or coma. Cardiovascular effects may include hypertension or hypotension. In case of suspected overdose, seek immediate medical attention. Treatment is supportive and symptomatic. Gastric lavage or activated charcoal may be administered if presentation is early. Hemodialysis is not effective due to high protein binding. Monitor electrolyte balance, renal function, and cardiovascular status closely. Specific antidotes are not available. Provide symptomatic treatment for gastrointestinal effects and maintain adequate hydration.
Storage
Store at room temperature (20-25°C or 68-77°F) in a dry place protected from light and moisture. Keep capsules in their original container with the lid tightly closed. Do not store in bathroom cabinets where humidity levels fluctuate. Oral suspension should be shaken well before use and discarded after the expiration date. Suppositories should be stored in refrigerator (2-8°C or 36-46°F) and removed 30 minutes before use to reach room temperature. Keep all medications out of reach of children and pets. Do not transfer medications to other containers. Properly dispose of expired or unused medication through medication take-back programs or according to FDA guidelines.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual patient needs may vary significantly. Always consult with a qualified healthcare professional before starting, changing, or stopping any medication. The prescribing physician should make all treatment decisions based on individual patient characteristics and medical history. This information is not exhaustive and does not cover all possible uses, directions, precautions, or interactions. Emergency medical situations require immediate professional attention. Never disregard professional medical advice or delay seeking it because of information contained herein.
Reviews
Clinical studies demonstrate Indocin’s efficacy in managing inflammatory conditions, with 70-80% of rheumatoid arthritis patients showing significant improvement. Many patients report substantial pain relief within the first week of treatment. However, gastrointestinal side effects are frequently noted in patient reports, with approximately 20% discontinuing therapy due to tolerability issues. Physicians note its particular effectiveness in acute gout management, often providing relief within 24 hours. The availability of multiple formulations is praised for allowing individualized treatment approaches. Long-term users emphasize the importance of regular monitoring for adverse effects. Overall, when properly monitored, Indocin remains a valuable option for managing inflammatory conditions that have not responded adequately to other NSAIDs.